Home › Funds › SABBY MANAGEMENT, LLC › TPST

SABBY MANAGEMENT, LLC position in TPST

TEMPEST THERAPEUTICS INC · Health Care

SABBY MANAGEMENT, LLC reported holding 511,286 shares of TPST (TEMPEST THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$568K, representing 4.13% of its reported portfolio and ranking #7 among its reported holdings. SABBY MANAGEMENT, LLC has disclosed TPST holdings in 4 of the last 5 reported quarters, going back to Q2 2025.

Latest position (Q2 2026)511.29K sh
Reported value held$567.53K
Portfolio Weight4.13%
First reportedQ2 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SABBY MANAGEMENT, LLC's TPST position evolved

SABBY MANAGEMENT, LLC first disclosed a stake in TPST in Q2 2025 at 276,587 shares (US$1.9M). Across 4 filings, SABBY MANAGEMENT, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 511,286 shares valued at US$568K — an increase of 493,430 shares quarter over quarter.. Notable position changes include a 90% trim in Q1 2026 (shares fell 32% over the following quarter), a 2763% increase in Q2 2026 (shares fell 25% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 276.59K $1.88M New
Q4 2025 178.59K $512.56K New
Q1 2026 17.86K $29.28K Reduce
Q2 2026 511.29K $567.53K Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TPST and 13F data

TPST (TEMPEST THERAPEUTICS INC) is a Health Care company. 21 other funds we track also report a position in TPST — the largest reported positions include Versant Venture Management, LLC (US$299K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TPST

All TPST fund holders →

FAQ

How long has SABBY MANAGEMENT, LLC held TPST?

SABBY MANAGEMENT, LLC has disclosed TPST holdings in 4 of the last 5 reported quarters, going back to Q2 2025.

What is SABBY MANAGEMENT, LLC's current position in TPST?

As of Q2 2026, SABBY MANAGEMENT, LLC holds 511.29K shares of TPST (TEMPEST THERAPEUTICS INC), valued at $567.53K, representing 4.13% of its reported portfolio and ranking #7.

Has SABBY MANAGEMENT, LLC been buying or selling TPST?

In the latest 13F filing (Q2 2026), SABBY MANAGEMENT, LLC increased its position in TPST.

Which other funds hold TPST?

Other major institutional holders of TPST include Versant Venture Management, LLC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.